Pedro M. García-Barrantes

Discovery of Potent Myeloid Cell Leukemia 1 (Mcl-1) Inhibitors Using Fragment-Based Methods and Structure-Based Design

Anders Friberg, Dominico Vigil, Bin Zhao et al. · Journal of Medicinal Chemistry · 2012 · 302 citations · Full text

Lead Compounds, Drug Target, Large Fragment Library +16

A Novel M ₁ PAM VU0486846 Exerts Efficacy in Cognition Models without Displaying Agonist Activity or Cholinergic Toxicity

Jerri M. Rook, Jeanette L. Bertron, Hyekyung P. Cho et al. · ACS Chemical Neuroscience · 2018 · 63 citations · Full text

Synthesis and biological evaluation of novel ferrocene–naphthoquinones as antiplasmodial agents

Pedro M. García-Barrantes, Guy Lamoureux, Alice L. Pérez et al. · European Journal of Medicinal Chemistry · 2013 · 60 citations · Full text

Bioorganic Chemistry, Biochemistry, Natural Sciences +5

Diverse Effects on M₁ Signaling and Adverse Effect Liability within a Series of M₁ Ago-PAMs

Jerri M. Rook, Masahito Abe, Hyekyung P. Cho et al. · ACS Chemical Neuroscience · 2016 · 56 citations

Chemical Modulation of Mutant mGlu₁ Receptors Derived from Deleterious <i>GRM1</i> Mutations Found in Schizophrenics

Hyekyung P. Cho, Pedro M. García-Barrantes, John T. Brogan et al. · ACS Chemical Biology · 2014 · 54 citations · Full text

Deleterious Nssnps, Synaptic Signaling, Social Sciences +17